CTI BIOPHARMA CORP. STOCK OPTION AGREEMENT (GLOBAL FORM)Stock Option Agreement • November 5th, 2015 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledNovember 5th, 2015 Company Industry JurisdictionTHIS STOCK OPTION AGREEMENT, including any country-specific appendices attached hereto, (collectively the “Option Agreement”) is dated as of [____________, 20__] (the “Grant Date”) by and between CTI BioPharma Corp., a Washington corporation (the “Corporation”), and [___________________] (the “Participant”). Capitalized terms used herein and not otherwise defined shall have the meaning assigned to such terms in the Plan.
CTI BIOPHARMA CORP. RESTRICTED STOCK UNIT AWARD AGREEMENT (GLOBAL FORM)Restricted Stock Unit Award Agreement • November 5th, 2015 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledNovember 5th, 2015 Company Industry JurisdictionTHIS RESTRICTED STOCK UNIT AWARD AGREEMENT, including any country-specific appendices attached hereto, (collectively the “Award Agreement”) is dated as of [___________, 20__] (the “Grant Date”) by and between CTI BioPharma Corp., a Washington corporation (the “Corporation”), and [______________] (the “Participant”).
CTI BIOPHARMA CORP. STOCK BONUS AWARD AGREEMENT (GLOBAL FORM)Equity Incentive Plan • November 5th, 2015 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledNovember 5th, 2015 Company Industry JurisdictionTHIS STOCK BONUS AWARD AGREEMENT, including any country-specific appendix attached hereto, (collectively the “Award Agreement”) is dated as of [___________, 20__] (the “Grant Date”) by and between CTI BioPharma Corp., a Washington corporation (the “Corporation”), and [______________] (the “Participant”).
CTI BIOPHARMA CORP. RESTRICTED STOCK AWARD AGREEMENTRestricted Stock Award Agreement • November 5th, 2015 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledNovember 5th, 2015 Company Industry JurisdictionTHIS RESTRICTED STOCK AWARD AGREEMENT (the “Award Agreement”) is dated as of [___________, 20__] (the “Grant Date”) by and between CTI BioPharma Corp., a Washington corporation (the “Corporation”), and [______________] (the “Participant”).